» Articles » PMID: 30792501

Neuron-glia Interactions in the Pathophysiology of Epilepsy

Overview
Specialty Neurology
Date 2019 Feb 23
PMID 30792501
Citations 169
Authors
Affiliations
Soon will be listed here.
Abstract

Epilepsy is a neurological disorder afflicting ~65 million people worldwide. It is caused by aberrant synchronized firing of populations of neurons primarily due to imbalance between excitatory and inhibitory neurotransmission. Hence, the historical focus of epilepsy research has been neurocentric. However, the past two decades have enjoyed an explosion of research into the role of glia in supporting and modulating neuronal activity, providing compelling evidence of glial involvement in the pathophysiology of epilepsy. The mechanisms by which glia, particularly astrocytes and microglia, may contribute to epilepsy and consequently could be harnessed therapeutically are discussed in this Review.

Citing Articles

Proinflammatory cytokines, oxidative stress, and organ function as biomarkers of soman (GD) chronic neurotoxicity.

Massey N, Vasanthi S, Gimenez-Lirola L, Tyler H, Thippeswamy T Sci Rep. 2025; 15(1):9021.

PMID: 40089647 DOI: 10.1038/s41598-025-94190-z.


Phagocytic Function Analyses of GABR-Related Microglia in Immature Developing Epileptic Brain Based on 10× Single-Nucleus RNA Sequencing Technology.

Gan Y, Yang X, Li T, Han Z, Cheng L, Xie L Biomedicines. 2025; 13(2).

PMID: 40002683 PMC: 11853619. DOI: 10.3390/biomedicines13020269.


Berberine Alleviates Kainic Acid-Induced Acute Epileptic Seizures in Mice via Reshaping Gut Microbiota-Associated Lipid Metabolism.

Dai W, Zhu Y, Jiang Z, Xiang Y, Mao X, Liu Z CNS Neurosci Ther. 2025; 31(2):e70253.

PMID: 39915895 PMC: 11802332. DOI: 10.1111/cns.70253.


Activity-based chemical proteomics reveals caffeic acid ameliorates pentylenetetrazol-induced seizures by covalently targeting aconitate decarboxylase 1.

Li G, Huang L, Gu D, Wang P, Yi L, Kuang W Cell Commun Signal. 2025; 23(1):62.

PMID: 39901156 PMC: 11792687. DOI: 10.1186/s12964-024-01739-y.


Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.

Luo Q, Yang J, Yang M, Wang Y, Liu Y, Liu J Mater Today Bio. 2025; 31:101457.

PMID: 39896289 PMC: 11786670. DOI: 10.1016/j.mtbio.2025.101457.


References
1.
Buckmaster P, Abrams E, Wen X . Seizure frequency correlates with loss of dentate gyrus GABAergic neurons in a mouse model of temporal lobe epilepsy. J Comp Neurol. 2017; 525(11):2592-2610. PMC: 5963263. DOI: 10.1002/cne.24226. View

2.
Eid T, Williamson A, Lee T, Petroff O, de Lanerolle N . Glutamate and astrocytes--key players in human mesial temporal lobe epilepsy?. Epilepsia. 2008; 49 Suppl 2:42-52. DOI: 10.1111/j.1528-1167.2008.01492.x. View

3.
Robert S, Buckingham S, Campbell S, Robel S, Holt K, Ogunrinu-Babarinde T . SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Sci Transl Med. 2015; 7(289):289ra86. PMC: 4503260. DOI: 10.1126/scitranslmed.aaa8103. View

4.
Perosa S, Porcionatto M, Cukiert A, Martins J, Passeroti C, Amado D . Glycosaminoglycan levels and proteoglycan expression are altered in the hippocampus of patients with mesial temporal lobe epilepsy. Brain Res Bull. 2002; 58(5):509-16. DOI: 10.1016/s0361-9230(02)00822-5. View

5.
van der Hel W, Notenboom R, Bos I, van Rijen P, van Veelen C, De Graan P . Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy. Neurology. 2005; 64(2):326-33. DOI: 10.1212/01.WNL.0000149636.44660.99. View